Invention Grant
- Patent Title: Phthalazinone compounds and methods for the treatment of cystic fibrosis
-
Application No.: US15615466Application Date: 2017-06-06
-
Publication No.: US10280160B2Publication Date: 2019-05-07
- Inventor: Bridget M. Cole
- Applicant: FLATLEY DISCOVERY LAB, LLC
- Applicant Address: US MA Charlestown
- Assignee: FLATLEY DISCOVERY LAB, LLC
- Current Assignee: FLATLEY DISCOVERY LAB, LLC
- Current Assignee Address: US MA Charlestown
- Agency: Elmore Patent Law Group, P.C.
- Agent Edgar W. Harlan; Carolyn S. Elmore
- Main IPC: C07D237/32
- IPC: C07D237/32 ; C07D413/12 ; A61K31/502 ; A61K45/06 ; C07D413/14 ; C07D498/04 ; A61K31/38 ; A61K31/4245 ; A61K31/443 ; A61K31/47 ; A61K31/5025 ; A61K31/506 ; A61K31/519 ; C07D401/04 ; C07D401/06 ; C07D405/04 ; C07D405/12 ; C07D405/14 ; C07D487/04 ; A61K31/5377 ; C07D401/12 ; C07D401/14 ; C07D403/04 ; C07D417/14 ; C07D495/14 ; C07D519/00
Abstract:
The invention relates to a compound of Formula I and methods of treating CFTR (cystic fibrosis transmembrane conductance regulator) mediated diseases, in particular cystic fibrosis, comprising the step of administering a therapeutically effective amount of a compound of Formula I to a patient in need thereof:
Public/Granted literature
- US20180044330A1 PHTHALAZINONE COMPOUNDS AND METHODS FOR THE TREATMENT OF CYSTIC FIBROSIS Public/Granted day:2018-02-15
Information query
